Fresenius today successfully placed bonds with an aggregate volume of €1.3 billion across two tranches: • €750 million bonds with a maturity in May 2025 and an annual coupon of 1.875% and • €550 million bonds with a maturity in May 2030 and an annual coupon of 2.875%. The proceeds will be used for general Read more about Fresenius successfully places bonds with a volume of 1.3 billion euros[…]
Despite ongoing burdens from the pandemic, the war in Ukraine and other external factors, the global healthcare group Fresenius remains on course for growth. This was confirmed by Stephan Sturm, CEO of Fresenius, at today’s Annual General Meeting: “We have some challenges to overcome, no question! But our path is clear. We have set strategic Read more about Annual General Meeting: Fresenius remains on course for growth despite ongoing burdens; 29th consecutive dividend increase approved[…]
The Fresenius Management SE Supervisory Board has unanimously appointed Sara Hennicken (41), currently Senior Vice President Global Treasury & Corporate Finance at Fresenius, to become the company’s new Chief Financial Officer as of September 1, 2022. She will succeed Rachel Empey (45), who joined the Management Board of Fresenius as CFO on August 1, 2017 Read more about Fresenius appoints Sara Hennicken as Chief Financial Officer – Rachel Empey to leave company at own request[…]
. – Fresenius Medical Care in line with its expectations countering significant headwinds – Fresenius Kabi’s solid financial performance based on strong Emerging Markets growth • Fresenius Helios’ strong performance driven by growing admissions in Germany and Spain – Fresenius Vamed with continued progress towards normal operations, very good performance in the service business – Read more about Fresenius with solid start to 2022 despite macroeconomic challenges[…]